CClinicalTrials.gg
Status unknownNCT05275413Updated Aug 22, 2022

mHealth Intervention to Reduce Maternal Postnatal Depression and Promote Family Health

An interventional study of family-based mHealth Intervention and mother-only mHealth Intervention in Postnatal Depression, Quality of Life and Family Relations, sponsored by The Hong Kong Polytechnic University. Status unknown at 2 sites in Hong Kong. Per ClinicalTrials.gov, last updated 2022-08-22.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Aug 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,578
Allocation
Randomized
Sex
All
01

Study summary

The proposed study is to test the effectiveness of a culturally-attuned, family-based mobile health (mHealth) intervention in reducing symptoms of postnatal depression and promoting health among expectant mothers in Hong Kong. Using a family perspective, the proposed mHealth intervention will engage family members, including expectant fathers and grandparents, in providing support to expectant mothers. Expectant mothers and their family members will be recruited at antenatal clinics at two public hospitals in Hong Kong and randomized to receive the family-based mHealth intervention (experimental), the mother-only mHealth intervention (experimental), or the health education (control). Maternal depression, anxiety and stress, perceived social support, health-related quality of life, and perceived family cohesion will be assessed at recruitment and four weeks after childbirth. For family members, symptoms of anxiety and stress, health-related quality of life, and perceived family cohesion will be measured.

Read the detailed description

Postnatal depression is a prevalent health issue affecting women. Although empirical evidence has proven the effectiveness of face-to-face antenatal classes in reducing perinatal distress, the availability of such support is often limited and is insufficient to benefit all parents who need it. Another challenge in pregnancy support is the difficulty to engage family members in providing support to expectant mothers. To address these limitations, the proposed project aims to develop and test the effectiveness of a family-based mobile health (mHealth) intervention, which will engage family members, including expectant fathers and grandparents to provide support to expectant mothers.

Specifically, the family-based mHealth intervention consists of a smartphone app with different versions designed for expectant mothers, fathers, and grandparents. The smartphone app will provide a user-friendly platform for users to receive psychoeducation materials related to pregnancy (e.g. antenatal care, postnatal care, and infant care) and an interactive forum for all users to ask questions related to pregnancy and family communication, which will be answered by health and social care professionals. To enhance family's engagement, we will also include other functions in the app to encourage communications among family members and enhance family cohesion. These functions include a platform for family members to send texts and share photos, and a shared schedule with alerts for dates related to pregnancy (e.g. appointments for antenatal check-ups and expected delivery date).

Using a randomized controlled design, the proposed study will evaluate the effectiveness of the family-based mHealth intervention in reducing maternal postnatal depression and promoting health in expectant mothers and their family members (expectant fathers and grandparents). The study will recruit 1,578 expectant mothers and their family members at the antenatal clinics at two selected public hospitals in Hong Kong. The participants will be randomized into three groups (i) family-based mHealth intervention; (ii) mother-only mHealth intervention; and (iii) health information control. Participants will be asked to complete a survey with question items related to their physical and mental health, perceived social support and family cohesion, at recruitment and four weeks after childbirth.

It is hypothesized that the family-based mHealth intervention is more effective in reducing symptoms of postnatal depression, promoting health of expectant mothers and their family members, and promoting family cohesion than the mother-only mHealth intervention and the control.

02

Conditions studied

  • Postnatal Depression
  • Quality of Life
  • Family Relations
03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's planned enrollment of 1,578 is above the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Expectant mothers (18 years old or above) attending the antenatal clinics at two public hospitals, Kwong Wah Hospital and Tsan Yuk Hospital in Hong Kong and their family members.
  2. Possession of a smartphone and a personal email address for receiving and sending information relevant to the study.
  3. Willing to accept the study arrangements.

Exclusion criteria

Exclusion Criteria:

  1. Not able to understand written or spoken Chinese.
  2. Expectant mothers whose EPDS score is equal to or high than the cut-off score of 10.
  3. Not willing or not able to provide informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,578 participants (estimated)

Study arms

  • Experimental
    family-based mHealth intervention

    The expectant mothers and their family members (fathers and grandparents) in this group will receive health education and support and family support via a smartphone app.

    Behavioral: family-based mHealth Intervention

  • Experimental
    mother-only mHealth intervention

    The expectant mothers in this group will receive health education and support via a smartphone app.

    Behavioral: mother-only mHealth Intervention

  • Active comparator
    Health education

    The expectant mothers in the control group will receive health education via a smartphone app.

    Other: Health education

Interventions

  • Behavioralfamily-based mHealth Intervention

    The intervention consists of three versions: mother, father, and grandparent. The app consists of health information about pregnancy, postnatal care, and infant care in the form of brief texts and short videos. Each versions have their unique features, such as a platform to ask questions in mother version, a quiz game to promote fathers' knowledge related to father's involvement, educational materials tailored for grandparents. An obstetrician and a social worker will respond to the questions. Details please refer to the proposal.

  • Behavioralmother-only mHealth Intervention

    The expectant mothers in this group will receive information about pregnancy, postnatal care, and infant care in the form of brief texts and short videos via a smartphone app. The expectant mothers will also have access to a platform in the smartphone app to ask questions about their pregnancy. An obstetrician will respond to the questions.

  • OtherHealth education

    The expectant mothers in the control group will receive information about pregnancy, postnatal care, and infant care in the form of brief texts and short videos via a smartphone app.

06

What researchers measure

Primary outcomes

  1. Postnatal depression symptoms

    Symptoms of maternal depression at four weeks postpartum will be assessed with the validated Chinese version of the 10-item Edinburgh Postnatal Depression Scale (EPDS).

    Time frame: 24 weeks after start of intervention

Secondary outcomes

  1. Perceived social support levels of expectant mothers

    Perceived social support levels of expectant mothers will be assessed with the Chinese version of the 12-item Multidimensional Scale of Perceived Social Support (MSPSS).

    Time frame: 24 weeks after start of intervention

  2. Anxiety and stress levels of all participants

    Anxiety and stress levels of all participants (including the expectant mothers, fathers, and grandparents) will be assessed with the Anxiety and Stress subscales of the Chinese version of the Depression Anxiety Stress Scale (DASS21).

    Time frame: 24 weeks after start of intervention

  3. Health-related quality of life (QoL) of all participants

    Health-related quality of life (QoL) of all participants will be measured with the validated Chinese version of the Short-form-12 Health survey (SF-12 v2), which consists of 12 items to be computed as two composite scores: physical component score and mental component score.

    Time frame: 24 weeks after start of intervention

  4. Perceived family cohesion levels of all participants

    Perceived family cohesion levels of all participants will be assessed using the nine-item Family Cohesion subscale of the Chinese version of the Family Environment Scale.

    Time frame: 24 weeks after start of intervention

07

Study locations

2 of 2 sites recruiting
  • Kwong Wah Hospital
    Hong Kong, Hong Kong
    • Wing Cheong Leung · Contact
    Recruiting
  • Tsan Yuk Hospital
    Hong Kong, Hong Kong
    • Ka Wang Cheung · Contact
    Recruiting
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 1, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05275413
Lead sponsor
The Hong Kong Polytechnic University
Collaborators
Kwong Wah Hospital, The University of Hong Kong, University of Glasgow, Tsan Yuk Hospital, Hong Kong
Responsible party
Dr Camilla Lo (Assistant Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Mar 11, 2022
Start date
Jun 16, 2022
Primary completion
Jun 30, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Aug 22, 2022

Study contacts

Camilla Kin Ming LO, Phd
Contact
camilla.lo@polyu.edu.hk
2766 5760

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion